Table 4.
Between-group comparisons of cost-effectiveness.
| Treatment | Costs (£) |
QALY |
Cost/effectiveness ratio (£/QALY) | ||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Between-treatment increment | Mean | SD | Between-treatment increment | ||
| Overall | |||||||
| Alginate (N = 71) | 363 | 43 | 26 | 0.06 | 0.02 | −0.004 | −5.758 (alginate dominates) |
| Silicone (N = 71) | 389 | 16 | 0.05 | 0.02 | |||
| Treatment | Costs (£) |
OHIP points |
Cost/effectiveness ratio (£/OHIP) | ||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Between-treatment increment | Mean | SD | Between-treatment increment | ||
| Overall | |||||||
| Alginate (N = 71) | 363 | 43 | 26 | 36.17 | 19.58 | 7.53 | 3.41 |
| Silicone (N = 70) | 389 | 18 | 28.64 | 18.92 | |||